{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:57:33Z","timestamp":1777946253614,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009109","name":"Bayer HealthCare AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejvs.2024.01.091","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T11:32:13Z","timestamp":1706959933000},"page":"969-978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Editor's Choice \u2013 Revascularisation for Peripheral Artery Disease in France: Implications for the Implementation of VOYAGER-PAD"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0322-9818","authenticated-orcid":false,"given":"Victor","family":"Aboyans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Morboeuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2373-1872","authenticated-orcid":false,"given":"Benjamin","family":"Grenier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Jolivel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7469-2407","authenticated-orcid":false,"given":"Alessandra","family":"Bura-Riviere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2024.01.091_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8295054","article-title":"Burden of coronary artery disease and peripheral artery disease: a literature review","volume":"2019","author":"Bauersachs","year":"2019","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ejvs.2024.01.091_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11739-011-0511-0","article-title":"The PANDORA study: peripheral arterial disease in patients with non-high cardiovascular risk","volume":"6","author":"Cimminiello","year":"2011","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ejvs.2024.01.091_bib3","first-page":"513","article-title":"Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis","volume":"23","author":"Emery","year":"2020","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.ejvs.2024.01.091_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.acvd.2019.05.009","article-title":"Epidemiology, treatment patterns and outcomes in patients with coronary or lower extremity artery disease in France","volume":"112","author":"Guedeney","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.ejvs.2024.01.091_bib5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jvs.2022.11.062","article-title":"Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits","volume":"77","author":"Govsyeyev","year":"2023","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.01.091_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.avsg.2021.02.025","article-title":"Incidence of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization","volume":"75","author":"Desai","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.01.091_bib7","first-page":"e686","article-title":"AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: Executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2016","journal-title":"Circulation 2017"},{"key":"10.1016\/j.ejvs.2024.01.091_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejvs.2023.04.026","article-title":"Nationwide study in France to predict one year major bleeding and validate the OAC3-PAD score in patients undergoing revascularisation for lower extremity arterial disease","volume":"66","author":"Lareyre","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.01.091_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/15266028211070967","article-title":"Outcome of femoral angioplasty\/stenting procedures in different ethnic groups in England: a retrospective analysis of hospital episode statistics and review of literature","volume":"30","author":"Vitalis","year":"2023","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2024.01.091_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/a-1535-2774","article-title":"Availability of interventional-radiological revascularization procedures in Germany\u2014an analysis of the DeGIR Registry Data 2018\/19","volume":"194","author":"Mahnken","year":"2022","journal-title":"Rofo"},{"key":"10.1016\/j.ejvs.2024.01.091_bib11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.120.047994","article-title":"Temporal changes in secondary prevention and cardiovascular outcomes after revascularization for peripheral arterial disease in Denmark: a nationwide cohort study","volume":"143","author":"S\u00f8gaard","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.01.091_bib12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jvs.2016.03.429","article-title":"Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization","volume":"64","author":"Sigvant","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.01.091_bib13","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/eht288","article-title":"Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis","volume":"34","author":"Malyar","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2024.01.091_bib14","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2024.01.091_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejvs.2021.10.026","article-title":"Revascularisation for symptomatic peripheral artery disease: external applicability of the VOYAGER PAD trial","volume":"63","author":"S\u00f8gaard","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.01.091_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejvs.2021.05.028","article-title":"Editor\u2019s Choice \u2013 External applicability of the COMPASS and VOYAGER-PAD trials on patients with symptomatic lower extremity artery disease in France: the COPART registry","volume":"62","author":"Lap\u00e9bie","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"Suppl 4","key":"10.1016\/j.ejvs.2024.01.091_bib17","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the Syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the Syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.ejvs.2024.01.091_bib18","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0140-6736(02)08594-X","article-title":"Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls","volume":"359","author":"Pocock","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2024.01.091_bib19","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2024.01.091_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/fcp.12326","article-title":"Positive predictive values of peripheral arterial and venous thrombosis codes in French hospital database","volume":"32","author":"Prat","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ejvs.2024.01.091_bib21","unstructured":"Dufour E, Herlemont P, Zureik M. Stents et ballons utilis\u00e9s dans l\u2019art\u00e9riopathie oblit\u00e9rante des membres inf\u00e9rieurs (AOMI) en France entre 2017 et 2019 : \u00e9tude men\u00e9e \u00e0 partir des donn\u00e9es du SNDS. EPI-PHARE 2021."},{"key":"10.1016\/j.ejvs.2024.01.091_bib22","first-page":"6433","article-title":"Temporal trends in patients with peripheral artery disease influenced by COVID-19 pandemic","volume":"11","author":"Keller","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ejvs.2024.01.091_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1358863X211021918","article-title":"North American lower-extremity revascularization and amputation during COVID-19: observations from the Vascular Quality Initiative","volume":"26","author":"Lou","year":"2021","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2024.01.091_bib24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ejvs.2023.02.071","article-title":"Editor\u2019s Choice \u2013 Impact of sex on the outcomes of patients undergoing repair for lower extremity peripheral arterial disease in France","volume":"65","author":"Raffort","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.01.091_bib25","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00330-021-08285-y","article-title":"In-patient care trends in peripheral artery disease in the German healthcare system over the past decade","volume":"32","author":"Decker","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejvs.2024.01.091_bib26","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1007\/s00270-022-03136-9","article-title":"Comparison and trends of endovascular, surgical and hybrid revascularizations and the influence of comorbidity in 1 million hospitalizations due to peripheral artery disease in Germany between 2009 and 2018","volume":"45","author":"Decker","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2024.01.091_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.11.050","article-title":"Long-term outcomes and associations with major adverse limb events after peripheral artery revascularization","volume":"75","author":"Hess","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2024.01.091_bib28","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jvs.2019.01.079","article-title":"A\u00a0systematic review and meta-analysis of risk factors for and incidence of 30-day readmission after revascularization for peripheral artery disease","volume":"70","author":"Smith","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.01.091_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejvs.2021.12.019","article-title":"The OAC3-PAD risk score predicts major bleeding events one year after hospitalisation for peripheral artery disease","volume":"63","author":"Behrendt","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.01.091_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ejvs.2023.03.042","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases","volume":"65","author":"Twine","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.01.091_bib31","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jvs.2017.09.041","article-title":"Outcomes and management costs of peripheral arterial disease in France","volume":"67","author":"Riviere","year":"2018","journal-title":"J\u00a0Vasc Surg"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588424001187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588424001187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:32:55Z","timestamp":1762363975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588424001187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1078588424001187"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.01.091","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editor's Choice \u2013 Revascularisation for Peripheral Artery Disease in France: Implications for the Implementation of VOYAGER-PAD","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.01.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society for Vascular Surgery. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}